OverviewSuggest Edit

Dante Labs is a genomics-as-a-service company engaged in genetic testing. It leverages data analysis algorithms and DNA sequencing techniques to provide customers with personalized reports. The company offers whole genome sequencing to help rare disease patients and manage users' nutrition, fitness, and well-being plans.

TypePrivate
Founded2016
HQNew York, NY, US
Websitedantelabs.com

Latest Updates

Employees (est.) (Jul 2021)107(+11%)
Revenue (FY, 2018)$2.3 M(+823%)
Cybersecurity ratingAMore

Key People/Management at Dante Labs

Andrea Riposati

Andrea Riposati

CEO
Mattia Capulli

Mattia Capulli

CSO & Co-Founder
Show more

Dante Labs Office Locations

Dante Labs has offices in New York, Lewes and L'Aquila
New York, NY, US (HQ)
379 W Broadway #538
Lewes, DE, US
16192 Coastal Hwy
New York, NY, US
349 5th Ave
L'Aquila, IT
Strada Statale 17 Loc. Boschetto di Pile
Show all (4)

Dante Labs Financials and Metrics

Summary Metrics

Founding Date

2016

Dante Labs total Funding

$748.2 k

Dante Labs latest funding size

$536.19 k

Time since last funding

3 years ago

Dante Labs investors

Dante Labs's latest funding round in April 2018 was reported to be $536.2 k. In total, Dante Labs has raised $748.2 k
Show all financial metrics

Dante Labs Revenue

Dante Labs's revenue was reported to be $2.31 m in FY, 2018 which is a 822.1% increase from the previous period.
USD

Revenue (FY, 2018)

2.3m

Revenue growth (FY, 2017 - FY, 2018), %

822.1%

Gross profit (FY, 2018)

1.3m

Gross profit margin (FY, 2018), %

54.8%

Net income (FY, 2018)

376.2k

EBIT (FY, 2018)

531.7k

Cash (31-Dec-2018)

338.9k
USDFY, 2016FY, 2017FY, 2018

Revenue

250.3k2.3m

Revenue growth, %

822%

Cost of goods sold

45.7k1.0m

Gross profit

204.6k1.3m
USDFY, 2016FY, 2017FY, 2018

Cash

193.5k100.2k338.9k

Accounts Receivable

4.3k33.0k

Inventories

16.8k

Current Assets

193.5k104.5k388.6k
USDFY, 2016FY, 2017FY, 2018

Net Income

(17.4k)(240.4k)376.2k

Depreciation and Amortization

154.0k

Inventories

(16.8k)

Accounts Payable

15.6k44.4k
USDFY, 2016

Debt/Equity

1.2 x

Debt/Assets

0.5 x

Financial Leverage

2.2 x
Show all financial metrics

Dante Labs Operating Metrics

FY, 2017FY, 2018

Average Order Value

$662

Countries

25

Patents and Patent Applications

11

Trademarks

22
Show all operating metrics

Dante Labs Acquisitions / Subsidiaries

Company NameDateDeal Size
Dante Labs Inc.
Dante Labs S.r.l.

Dante Labs Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

Dante Labs Online and Social Media Presence

Embed Graph

Dante Labs News and Updates

Dante Labs appoints Illumina acclaimed COO Bob Ragusa as Board Member to support the execution of its global integrated precision medicine strategy

CAMBRIDGE, United Kingdom, July 19, 2021 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, announced today the appointment of Bob Ragusa as a board member. Bob is the Chief Operations Officer of Illumina Inc. (NASDAQ: ILMN), the world leader in sequencing platform…

Dante Labs commits to ending Rare Disease Odysseys globally through Stripe2be: a patient-centric whole genome based solution tailored for rare disease patients

CAMBRIDGE, England, July 08, 2021 (GLOBE NEWSWIRE) -- Dante Labs, a leading genomics and diagnostics company, today announced the launch of Stripe2be, a platform and business unit fully dedicated to rare disease patients, offering personalized, AI-driven reports based on Whole Genome Sequencing an…

Dante Labs acquires Cambridge Cancer Genomics to create global excellence in precision oncology

CAMBRIDGE, United Kingdom, June 23, 2021 (GLOBE NEWSWIRE) -- Dante Labs, a leading genomics and diagnostics company, today announced the acquisition of Cambridge Cancer Genomics (CCG.ai), a groundbreaking Y-Combinator company & leader in machine learning for clinical oncology, to create a sing…

Dante Labs announces appointments of Paul Jones, Simon Partridge and Christian Bourne to turbo-charge global population genomics programmes

Paul Jones, Simon Partridge and Christian Bourne, previously from Illumina and Genomics England, have joined Dante Labs in its new Cambridge, UK office to spearhead its ground-breaking global population genomics offer Paul Jones, Simon Partridge and Christian Bourne, previously from Illumina and Gen…

Dante Labs £30M investment in Cambridge will support global COVID-19 sequencing surveillance program

Dante Labs has already analysed two million and a half COVID-19 RT-PCR tests and sequenced more than 30,000 human whole genomes thanks to its Immensa™ Genome Platform Dante Labs has already analysed two million and a half COVID-19 RT-PCR tests and sequenced more than 30,000 human whole genomes thank…

Dante Labs Launches Best Ever Black Friday Offer for Whole Genome

NEW YORK, Nov. 25, 2020 /PRNewswire/ -- Dante Labs announced today its new Black Friday - Cyber Monday offering for Whole Genome Sequencing and reports for 2020. This offering is a real step toward "personalized medicine for everyone" and allows everyone to access the most advanced...
Show more

Dante Labs Frequently Asked Questions

  • When was Dante Labs founded?

    Dante Labs was founded in 2016.

  • Who are Dante Labs key executives?

    Dante Labs's key executives are Andrea Riposati and Mattia Capulli.

  • How many employees does Dante Labs have?

    Dante Labs has 107 employees.

  • What is Dante Labs revenue?

    Latest Dante Labs annual revenue is $2.3 m.

  • What is Dante Labs revenue per employee?

    Latest Dante Labs revenue per employee is $21.6 k.

  • Who are Dante Labs competitors?

    Competitors of Dante Labs include Living DNA, Veritas Genetics and 23andMe.

  • Where is Dante Labs headquarters?

    Dante Labs headquarters is located at 379 W Broadway #538, New York.

  • Where are Dante Labs offices?

    Dante Labs has offices in New York, Lewes and L'Aquila.

  • How many offices does Dante Labs have?

    Dante Labs has 4 offices.